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a b s t r a c t
N-7 and 20-O methylation of host cell mRNA occurs in the nucleus and results in the generation of cap
structures (cap 0, m7GpppN; cap 1, m7GpppNm) that control gene expression by modulating nuclear
export, splicing, turnover, and protein synthesis. Remarkably, RNA cap modiﬁcation also contributes to
mammalian cell host defense as viral RNA lacking 20-O methylation is sensed and inhibited by IFIT1, an
interferon (IFN) stimulated gene (ISG). Accordingly, pathogenic viruses that replicate in the cytoplasm
have evolved mechanisms to circumvent IFIT1 restriction and facilitate infection of mammalian cells.
These include: (a) generating cap 1 structures on their RNA through cap-snatching or virally-encoded
20-O methyltransferases, (b) using cap-independent means of translation, or (c) using RNA secondary
structural motifs to antagonize IFIT1 binding. This review will discuss new insights as to how speciﬁc
modiﬁcations at the 50-end of viral RNA modulate host pathogen recognition responses to promote
infection and disease.
& 2015 Elsevier Inc. All rights reserved.
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Pathogen associated molecular patterns (PAMPs) that are unique
to viral RNA (e.g., double-stranded RNA or 50-ppp-RNA) are recog-
nized by Toll-like receptors (TLR3, TLR7, and TLR8) and the RIG-I-
like receptors (RLR: RIG-I and MDA-5) in the host cell endosome
and cytoplasm. Upon binding their respective PAMPs these patho-
gen recognition receptors (PRRs) trigger signaling cascades that
induce nuclear translocation of transcription factors (IRF-3, IRF-7,
and NF-κB), which induce expression of antiviral type I interferons
(IFN-α and -β) (reviewed in Bowie and Unterholzner (2008)). IFN-α
and -β bind to and signal through the type I IFN receptor (IFNAR) in
an autocrine and paracrine manner to induce the expression of
hundreds of IFN-stimulated genes (ISGs) that have diverse antiviral
and immune regulatory functions. Recent studies have identiﬁed an
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additional PAMP on some viral mRNA lacking-20-O methylation,
which is recognized by the ISG Iﬁt1 (Habjan et al., 2013; Hyde et al.,
2014; Kimura et al., 2013; Menachery et al., 2014; Szretter et al.,
2012). As mRNA of higher eukaryotic organisms contain 20-O
methylation on their 50 cap structures, Iﬁt1 may have evolved, in
part, to distinguish self from non-self RNA.
Eukaryotic N-7- and 20-O- methylation of host mRNA
RNA methylation is a common post-transcriptional modiﬁcation
that regulates gene expression by inﬂuencing diverse aspects of RNA
biology including nuclear export, splicing, transcript stability, and
translation. In eukaryotic cells, host mRNAs are capped at the 50 end
by an inverted N-7 methyl guanosine nucleoside (m7GpppN), which
is linked to the RNA moiety by a triphosphate bridge (Fig. 1A). The
presence of the m7G cap (cap 0) structure enhances mRNA transla-
tion by promoting the association of translation initiation factors
such as eIF4E with the 50 end, as transcripts lacking methylated 50
caps fail to complex efﬁciently with 40S ribosomal subunits (Both
et al., 1975; Gebauer and Hentze, 2004; Shatkin, 1985). Additionally,
methylated 50 cap structures stabilize RNA transcripts by preventing
degradation by 50-30 cellular exoribonucleases (reviewed in (Garneau
et al., 2007)), and regulate early steps in RNA transcription by
associating with gene promoters (reviewed in (Bentley, 2005; Pei
et al., 2003; Schroeder et al., 2000)).
Addition of the m7G cap occurs co-transcriptionally in the nucleus
via a three-step enzymatic reaction (Fig. 1B). Newly transcribed RNA
(pppNp-RNA) is cleaved by RNA triphosphatase at the γ-phosphate
to yield diphosphate RNA (ppNp-RNA) (Yagi et al., 1983). Guanylyl-
transferase, which forms part of the bifunctional capping enzyme
(hCAP) that also encodes triphosphatase activity, then hydrolyzes the
α-phosphate from GTP and transfers the GMP moiety to the ppNp-
RNA acceptor to generate GpppNp (Venkatesan et al., 1980;
Venkatesan and Moss, 1980; Yagi et al., 1983; Yamada-Okabe et al.,
1998). This reaction shows speciﬁcity for ppNp-RNA as pppNp-RNA is
capped far less efﬁciently, and pNp-RNA not at all. GpppNp-RNA is
then methylated by a distinct enzyme, (guanine-N-7-)methyltrans-
ferase (N-7 MTase), which modiﬁes the 50 terminal guanosine of
dinucleoside and polynucleoside triphosphate moieties (Ensinger
and Moss, 1976). In this reaction the N-7 MTase transfers a methyl
group from an S-adenosyl-L-methionine (AdoMet) donor to the
Fig. 1. Overview of cap 1 structure formation in eukaryotic and viral systems. (A) Chemical structure of the G-cap and methylation sites which form cap 0, cap 1, and cap
2 structures. (B) The eukaryotic canonical capping pathway. Newly transcribed RNA (pppNp-RNA) is cleaved by RNA triphosphatase at the γ-phosphate to yield diphosphate
RNA (ppNp-RNA). Guanylyltransferase, which forms part of the bifunctional capping enzyme (hCAP) that also encodes triphosphatase activity, then hydrolyzes the α-
phosphate from GTP and transfers the GMP moiety to the ppNp-RNA acceptor to generate GpppNp. GpppNp-RNA is methylated by the N-7 MTase, which transfers a methyl
group from an S-adenosyl-L-methionine (AdoMet) donor to the unmethylated G-cap acceptor, producing cap 0 RNA (m7GpppNp) and S-adenosyl-L-homocysteine (AdoHcy)
as a by-product. The 20-O-ribose MTase (hMTr1) then transfers a methyl group from the AdoMet donor to the ﬁrst and second nucleotides of cap 0 RNA to generate cap 1 and
cap 2 structures, respectively. (C) Generation of viral cap 1 structures through non-canonical capping and methylation pathways. Analogous to eukaryotic RNA methylation,
some viruses (e.g. coronavirus and poxvirus) catalyze cap 0 and cap 1 formation separately via two distinct enzymes or enzymes complexes (left). In contrast, other viruses
(e.g. ﬂavivirus and reovirus) catalyze N-7 and 20-O methylation sequentially via a single enzyme (right). Although the cap 1 end product is identical between host and viral
transcripts structural differences in the viral and eukaryotic enzymes that catalyze these reactions and their distinct modes of ligand binding make viral 20-O MTases
potential targets for inhibitor design.
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unmethylated G-cap acceptor, producing cap 0 RNA (m7GpppNp)
and S-adenosyl-L-homocysteine (AdoHcy) as a by-product.
Whereas N-7-methylation is conserved among all eukaryotes,
20-O-ribose methylation of the ﬁrst or the ﬁrst and second tran-
scribed nucleotides immediately downstream of the m7G cap (which
forms cap 1 and cap 2 structures, respectively) is present only in
mRNA of bony ﬁsh and higher eukaryotes (Varela et al., 2014). The
additional 20-O methylation event and generation of cap 1 structures
facilitates splicing of small nuclear RNAs (snRNA) (Donmez et al.,
2004) and enhances translation of mRNA during oocyte maturation
(Kuge et al., 1998; Kuge and Richter, 1995). Beyond these functions,
20-O methylation and cap 1 structures contribute to the recognition
and restriction of non-self RNA, particularly in the context of the cell-
intrinsic immune response to viruses (Dafﬁs et al., 2010; Habjan et
al., 2013; Hyde et al., 2014; Kimura et al., 2013). Indeed, expression of
the MTase (hMTr1, also known as ISG95) that catalyzes formation of
cap 1 structures is augmented by interferon (IFN), supporting a role
for differential methylation of RNA cap structures in immune detec-
tion and restriction (Haline-Vaz et al., 2008).
20-O-ribose methylation of host cell mRNA occurs co-trans-
criptionally in the nucleus through the actions of hMTr1 (Belanger
et al., 2010; Pei et al., 2003; Schroeder et al., 2000). Analogous to the
nuclear N-7 MTase, hMTr1 associates with Pol II (Haline-Vaz et al.,
2008) and can methylate both m7GpppG and GpppG RNA in vitro
(Belanger et al., 2010; Langberg and Moss, 1981; Smietanski et al.,
2014). The crystal structure of the human 20-O-MTase catalytic
domain complex (Smietanski et al., 2014) has revealed that recogni-
tion of the guanosine cap by eukaryotic and viral 20-O-MTases
occurs in a distinct manner (Egloff et al., 2002, 2007; Hodel et al.,
1998). Proposed differences in the structural interaction of host
and viral 20-O-MTases with their RNA ligands has been used as
the basis for development of targeted viral MTase inhibitors, as
discussed below.
20-O-methylation and host-mediated restriction of viral RNA
20-O methylation of cap structures contributes to the sensing of
non-self RNA and restriction of viral replication and pathogenesis.
Iﬁt1, an IFN-induced RNA-binding protein, mediates this effect by
preferentially binding to viral RNAs lacking 20-O-methylation at their
50 end and inhibiting RNA translation (Dafﬁs et al., 2010; Kimura
et al., 2013; Kumar et al., 2014; Li et al., 2013; Menachery et al., 2014;
Szretter et al., 2012; Zhang et al., 2014; Zust et al., 2011, 2013).
Introduction of loss-of-function point mutations into the catalytic
tetrad (KDKE) of ﬂavivirus, coronavirus, and poxvirus 20-O-MTases
(e.g., West Nile virus NS5-E218A, Japanese encephalitis virus NS5-
E218A, Dengue virus NS5-E216A and E217A, mouse hepatitis virus
NSP16 D130A, human coronavirus 229E NSP16-D129A, SARS-
coronavirus NSP16-D130A, and vaccinia virus J3-K175R) resulted in
attenuated virus infections both in vitro and in vivo (Dafﬁs et al.,
2010; Kimura et al., 2013; Kumar et al., 2014; Li et al., 2013;
Menachery et al., 2014; Szretter et al., 2012; Zhang et al., 2014;
Zust et al., 2011, 2013). Mutations that abrogated 20-O methylation
were associated with decreased viral replication in wild-type mice
and cells, and an increased sensitivity to the antiviral actions of type I
IFN. Replication and virulence was restored in the absence of an
intact IFN signaling response or Iﬁt1 (Dafﬁs et al., 2010; Szretter et al.,
2012; Zust et al., 2011) in primary cell culture (dendritic cells,
macrophages, and neurons) or in vivo. Attenuated 20-O-MTase
mutant viruses have potential as vaccines as they retain immuno-
genicity and confer protection against challenge with pathogenic
ﬂaviviruses, rhabdoviruses, and coronaviruses (Li et al., 2013; Ma
et al., 2014; Menachery et al., 2014; Zhang et al., 2014; Zust et al.,
2013).
Iﬁt1 belongs to a family of IFN-induced proteins (human IFIT1
and IFIT1B, IFIT2, IFIT3, and IFIT5; mouse Iﬁt1, Iﬁt1b, Iﬁt1c, Iﬁt2, and
Iﬁt3) that are induced rapidly and expressed to high levels in an
IFN-dependent and -independent manner following virus infection
(Guo et al., 2000b; Kitamura et al., 2001; Sharma et al., 2003; Smith
and Herschman, 1996; Terenzi et al., 2005). IFIT genes exhibit low
sequence identity between both orthologs and paralogs (31% to
69%) but are related by their multiple tetratricopeptide repeat (TPR)
domains (Smith and Herschman, 1996). The TPR motif comprises a
degenerate 34 amino-acid sequence containing eight loosely
conserved hydrophobic residues, and is important in mediating
protein–protein interactions (Goebl and Yanagida, 1991; King et al.,
1995; Lamb et al., 1995; Terlecky et al., 1995; Tzamarias and Struhl,
1995). TPR motifs form an amphipathic antiparallel helix and higher
order helical structures, although the overall structure may vary
considerably among proteins (reviewed in D’Andrea and Regan
(2003)).
The crystal structures of the N-terminus of human IFIT1, the full-
length IFIT2 homodimer, and full-length IFIT5 monomer have helped
to elucidate how IFIT proteins interact with RNA ligands (Abbas
et al., 2013; Feng et al., 2013; Katibah et al., 2013; Yang et al., 2012).
Table 1
Summary of Iﬁt-ligand binding.
50-OH 50-ppp Cap
(GpppNp)
Cap 0
(7mGpppNp)
Cap 1
(7mGpppNm)
References
Human IFIT1 – – (41.4 μM) þ þ(2374 nM) – Habjan et al. (2013), Pichlmair et al., (2011), Kumar et al. (2014) and
Abbas et al. (2013)þ(242 nM)
Human IFIT1B þ þ Kumar et al. (2014)
Mouse Iﬁt1 – – þ þ – Habjan et al., (2013), Kimura et al. (2013) and Pichlmair et al. (2011)
þ
Mouse Iﬁt1c – þ – Habjan et al. (2013)
Rabbit IFIT1 –(41.4 μM) þ(2071 nM) – Kumar et al. (2014)
Rabbit IFIT1B – þ(972 nM) þ(457724 nM) Kumar et al. (2014)
Human IFIT2 – – – – – Habjan et al. (2013), Kumar et al. (2014), Pichlmair et al. (2011) and
Yang et al. (2012)þ(dsRNA) þ(dsRNA) þ
Mouse Iﬁt2 – – – Habjan et al. (2013)
Human IFIT3 – – – – – Abbas et al., (2013), Habjan et al., 2013, Kumar et al., 2014 and
Pichlmair et al. (2011)þ
Mouse Iﬁt3 – – – Habjan et al. (2013)
Human IFIT5 – þ(372721 nM) – – – Abbas et al. (2013), Feng et al. (2013), Habjan et al. (2013), Katibah
et al. (2014) and Kumar et al. (2014)þ(1.770.15 μM)(1.470.18 μM)
No or minimal binding (-), positive binding (þ). Dissociation constant (KD) is indicated in parentheses. Unavailable data is indicated by gray cells. Speciﬁcity for dsRNA
binding is indicated (dsRNA).
J.L. Hyde, M.S. Diamond / Virology 479-480 (2015) 66–7468
Although a complete structure of mouse or human Iﬁt1 has not been
determined, the sequence and structural homology between the
N-terminal subdomains of IFIT1 and IFIT5 suggest a conserved mode
of RNA ligand binding (Abbas et al., 2013). IFIT1, IFIT2, and IFIT5 all
form superhelical structures containing a highly positively charged
grove or pocket, which accommodates binding of different RNA
ligands. Although the precise mode and speciﬁcity of RNA binding
differs among IFIT proteins (Table 1), mutation of positively charged
residues lying within this pocket is sufﬁcient to abrogate RNA binding
(Abbas et al., 2013; Katibah et al., 2013; Kumar et al., 2014; Pichlmair
et al., 2011). IFIT1 may also undergo conformational changes upon
ligand binding, as has been observed for IFIT5 (Abbas et al., 2013;
Katibah et al., 2014). Unbound IFIT5 adopts a relatively open con-
formation near the binding pocket, presumably to facilitate interaction
with different RNA ligands; upon association with RNA, structural
changes result in a more closed conformation (Katibah et al., 2014).
Biochemical analysis also has contributed to our understanding
of the speciﬁcity and dynamics of Iﬁt1-RNA binding (Table 1). Initial
studies indicated that IFIT1 interacted with RNA transcripts contain-
ing 50-ppp moieties (Pichlmair et al., 2011) in a manner similar to
IFIT5 (Abbas et al., 2013; Feng et al., 2013; Katibah et al., 2013;
Pichlmair et al., 2011). Surface plasmon resonance, ﬁlter binding,
primer extension inhibition, and electromobility shift assays, all
have deﬁned a low afﬁnity (KD250 nM to41 μM) interaction
between IFIT1 and 50-ppp RNA (Kumar et al., 2014; Pichlmair et al.,
2011), with one study indicating this strength of binding was
sufﬁcient to sequester negative strand RNA and inhibit infection
of inﬂuenza A, vesicular stomatitis, and Rift Valley fever viruses
(Pichlmair et al., 2011). IFIT1/Iﬁt1 binds more avidly (KD9 to
30 nM) to viral or host cap 0 RNA lacking 20-O methylation in a
sequence-independent manner (Habjan et al., 2013; Hyde et al.,
2014; Kimura et al., 2013; Kumar et al., 2014). The binding of cap
0 RNA by IFIT1 appears unique as IFIT2/Iﬁt2, IFIT3/Iﬁt3, and IFIT5 fail
to bind with appreciable afﬁnity (Habjan et al., 2013; Kumar et al.,
2014). Although N-7-methylation of RNA (m7GpppNp-RNA) was not
required for IFIT1 binding, this modiﬁcation enhanced binding
to IFIT1 and IFIT1B compared to unmethylated G-capped RNA
(GpppNp-RNA). Nucleotides proximal to the methylated cap 0 and
triphosphate bridge likely modulate IFIT1-RNA interactions, as
primer extension assays suggest that at least 4 or 5 nucleotides
downstream of the cap 0 structure are bound by IFIT1 (Kumar et al.,
2014). Analogously, nucleotides proximal to cap structures also
Fig. 2. Iﬁt1 inhibits diverse aspects of RNA translation. Canonical cap-dependent translation proceeds as follows: (1) the 40S ribosomal subunit complexes with eIF3 and the
ternary complex (eIF2-GTP-Met-tRNA) to form the 43S pre-initiation complex. (2) eIF4E associates with the cap and recruits the eIF4F cap-binding complex (eIF4A, eIF4E,
eIF4G). (3) eIF4F facilitates unwinding of the RNA and the 43S pre-initiation complex is recruited to form the 48S complex. (4) The 48S complex scans along the mRNA for the
AUG initiator codon. (5) The 60S ribosomal subunit is recruited to the 48S complex to form the 80S initiator complex, which translates the mRNA. Iﬁt1/IFIT1 binds to subunits
of the eIF3 complex (a) to prevent ternary complex formation or 43S formation and recruitment (Guo et al., 2000a; Hui et al., 2003, 2005; Kumar et al., 2014; Wang et al.,
2003). (b) IFIT1 interaction with the 40S ribosomal subunit abrogates 48S formation (Kumar et al., 2014). (c) Iﬁt1/IFIT1 directly associates with cap 0 viral RNA and inhibits
recruitment of eIF4E and eIF4F to RNA.
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enhance binding of other cap-binding proteins to RNA (Chung
et al., 1994; Kumar et al., 2014). This concept is supported by recent
studies demonstrating that RNA secondary structure can inhibit
Iﬁt1 binding independent of cap methylation status (Hyde et al.,
2014), possibly through steric hindrance of Iﬁt1-RNA interactions.
The inﬂuence of N-7-methylation status of cap 0 structures on IFIT1
binding may be species-speciﬁc, as differences in ligand binding
afﬁnities were observed for rabbit IFIT1 (Kumar et al., 2014).
Varying ligand speciﬁcities of human IFIT1 and IFIT1B suggests
overlapping yet distinct biological functions of IFIT1-like genes. In
contrast to IFIT1, which binds cap 0 but not cap 1 RNA, the paralog
IFIT1B binds both cap 0 and cap 1 structures (Kumar et al., 2014).
This cap 1 binding activity has fostered the hypothesis that IFIT1B
has additional translational control functions in the absence of an
antiviral response. This is supported indirectly by the observations
that IFIT1B expression is not induced by IFN or PAMP stimulation
(Fensterl and Sen, 2011; Liu et al., 2013), and can bind non-viral
RNA ligands (Kumar et al., 2014).
Although IFIT1 has been implicated as an IFN-induced protein
that inhibits translation of viral mRNA, the precise mechanism has
remained unclear (Andrejeva et al., 2013; Guo et al., 2000a; Habjan
et al., 2013; Hui et al., 2003, 2005; Kimura et al., 2013; Kumar et al.,
2014; Wang et al., 2003). In canonical cap-dependent translation
(Fig. 2) (reviewed in Jackson et al. (2010)), the 40S ribosomal
subunit complexes with eIF3 and the ternary complex (eIF2-GTP-
Met-tRNA) to form the 43S pre-initiation complex. This pre-
initiation complex is recruited to mRNA via cap-binding complex
eIF4F (eIF4A, eIF4E, eIF4G), which together forms the 48S complex
and scans mRNA sequences for the AUG initiator codon. Earlier
studies suggested that Iﬁt1 and IFIT1 bind to subunits of the eIF3
complex to prevent downstream events required for translation
initiation (Guo et al., 2000a; Hui et al., 2003, 2005; Wang et al.,
2003). The interaction of IFIT1 with components of the eIF3
complex is species-speciﬁc, as human IFIT1 targets eIF3e, which
inhibits association with the ternary complex (Hui et al., 2003).
More recently, IFIT1 has been suggested to inhibit translation at the
step of 48S complex formation via interaction with the 40S subunit
(Kumar et al., 2014). In comparison, mouse Iﬁt1 reportedly interacts
with eIF3c to prevent eIF4F-mediated recruitment of the 43S
pre-initiation complex to RNA (Hui et al., 2005).
Iﬁt1 and IFIT1 initially were suggested to associate directly with
translation factors in an RNA-independent manner, effectively
sequestering them from the active translation pool. However, this
mechanism did not explain how IFIT1 preferentially could inhibit
viral versus host mRNA translation. Recent studies show that Iﬁt1
and IFIT1 directly bind cap 0 RNA and prevent recruitment of
translation factors (Habjan et al., 2013; Hyde et al., 2014; Kimura
et al., 2013; Kumar et al., 2014). Because of its relatively greater
afﬁnity for RNA lacking 20-O methylation, IFIT1 can out-compete
eIF4E or eIF4F for binding, and thus remove cap 0 RNA from the
actively translating pool (Kumar et al., 2014). Additionally, initiator
and elongator tRNAs also compete with cap 0 RNA for IFIT1 and
Fig. 3. Viral mechanisms of Iﬁt1 evasion and antagonism. Viruses generate cap 1 structures through (a) cap-snatching (orthomyxoviurses, bunyaviruses, arenaviruses)
whereby cap 1 is cleaved from host mRNA transcripts and used as a primer for viral RNA transcription. In contrast to orthomyxoviruses, which cap-snatch from mRNA in the
nucleus, bunyaviruses associate with and sequester cap 1 containing nonsense-mRNA transcripts in cellular P bodies where N protein protects cap 1 from degradation. Some
viruses mimic cap 1 structures via virally-encoded 20-O MTases (ﬂaviviruses, coronaviruses, rhabdoviruses, paramyxoviruses, reoviruses, and poxviruses). Other viruses
(picornaviruses, caliciviruses, and hepaciviruses) circumvent Iﬁt1-mediated restriction by using non-canonical cap-like structures (VPg) at their 50 end or IRES-mediated cap-
independent translation (b). Alphaviruses antagonize Iﬁt1 function directly by inhibiting association with viral RNA through the generation of stable secondary structures in
the 50-UTR (c).
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IFIT1B binding (Katibah et al., 2013, 2014), suggesting that IFIT1 may
inhibit protein synthesis of mRNA independent of cap methylation
status, by sequestering tRNAs from the translating pool (Kumar et al.,
2014). This study also demonstrated an association of IFIT1 with the
40S ribosomal subunit that was independent of RNA binding,
suggesting yet another mechanism of general translation inhibition.
The precise mechanism of translation inhibition may be inﬂuenced
by the potential of IFIT1 to form homo- or heterodimers with other
IFIT proteins (Habjan et al., 2013; Pichlmair et al., 2011). Although the
functional relevance of IFIT oligomerization requires exploration, it is
an attractive hypothesis by which the cell could use IFIT proteins to
modulate translation control under different cellular conditions.
Mechanisms of viral evasion of Iﬁt1-mediated restriction
Viruses have evolved diverse mechanisms to circumvent IFIT1-
mediated restriction including: (a) generating cap 1 structures on
their RNA by cap-snatching, or using virally- or host-encoded 20-O
MTases; (b) using cap-independent means of translation; or (c) using
RNA secondary structural motifs to antagonize Iﬁt1 binding (Fig. 3).
Viral 20-O MTases
Many RNA viruses that replicate in the cytoplasm (including
Flaviviruses, Coronaviruses, Poxviruses, Paramyxoviruses, Reoviruses,
and Rhabdoviruses) encode their own viral 20-O MTases, which
catalyze the formation of cap structures on viral mRNA that mimic
those present on host mRNAs. Mutant viruses encoding defective 20-O
MTases are sensitive to Iﬁt1-mediated restriction and attenuated
in vivo (Dafﬁs et al., 2010; Li et al., 2013; Menachery et al., 2014;
Szretter et al., 2012; Zust et al., 2011). Although cap 1 structures are
generated by virus-encoded MTases, the mechanism of cap methyla-
tion is distinct compared to eukaryotes (Fig 1C). Structural and
biochemical analysis of the MTases from eukaryotic hosts and viruses
have illustrated unique characteristics of viral 20-O MTases,
(Assenberg et al., 2007; Egloff et al., 2002, 2007; Hodel et al., 1998),
making them potential targets for drug development (reviewed in
Dong et al. (2008) and Ferron et al. (2012)).
In contrast to cap formation in eukaryotic cells and by certain
viruses (e.g., Poxviruses and Coronaviruses) where N-7 and 20-O
methylation is catalyzed by two enzymes, ﬂaviviruses, reoviruses,
and rhabdoviruses catalyze RNA methylation with a single viral
enzyme (Assenberg et al., 2007; Bujnicki and Rychlewski, 2001,
2002; Ferron et al., 2002; Hercyk et al., 1988; Ray et al., 2006;
Reinisch et al., 2000). The N-7 and 20-O MTase activities of ﬂavi-
viruses are encoded by the N-terminal domain of the NS5 gene (Ray
et al., 2006). The NS5 MTase domain of ﬂaviviruses possesses a
Rossmann-like superfold and comprises a catalytic core of a seven-
stranded β-sheet ﬂanked by α-helices (reviewed in Martin and
McMillan (2002) and Schubert et al. (2003)). The catalytic tetrad
(KDKE) of MTases is conserved in the ﬂaviviruses, poxviruses,
reoviruses, and coronaviruses (Assenberg et al., 2007; Decroly et al.,
2011; Egloff et al., 2002, 2007). Flavivirus MTase shows preferential
binding for GTP, m7GTP, and m7GpppA within the cap-binding
pocket. Substrates containing the ﬁrst two native nucleotides (AG)
of the ﬂavivirus genome bind with higher afﬁnity to the MTase than
non-native nucleotide substrates, which may account for why these
nucleotides are strictly conserved (Cleaves and Dubin, 1979; Egloff
et al., 2007). m7GpppA and GpppA substrates also bind with different
afﬁnities, perhaps due to different modes of interaction of these
substrates with the MTase (Egloff et al., 2002).
Reovirus capping and methylation is catalyzed by the λ2 protein,
which forms pentamers that comprises part of the reovirus core
(Koonin, 1993; Luongo et al., 1998; Reinisch et al., 2000). λ2 pentamers
form a cylindrical structure through which viral mRNA passes and is
capped and methylated at the N-7 and 20-O position. The spatial
arrangement of the catalytic sites within the λ2 pentamer indicates
that capping, N-7- and 20-O-methylation of viral RNA occurs sequen-
tially as it shuttles from one end of the pentamer to the other. The
presence of a ﬂap at the terminus of the pentamer has been suggested
to retain nascent viral RNA and ensure proper capping and methyla-
tion (Reinisch et al., 2000).
The N-7 and 20-OMTase activity of coronaviruses are encoded by
the viral NSP14 and NSP16 genes, respectively. While the corona-
virus NSP14 N-7 MTase modiﬁes nascent viral transcripts in a
sequence-independent manner (Chen et al., 2013) the 20-O MTase
is sequence-speciﬁc, and requires a second viral protein (NSP10) as
a cofactor (Chen et al., 2011; Decroly et al., 2008) for both RNA
substrate and AdoMet binding.
The poxvirus 20-O MTase VP39 catalyzes the formation of cap
1 structures. In contrast to reovirus λ2 and coronavirus NSP16, VP39
does not require oligmerization or cofactor binding for function
(Hodel et al., 1998, 1996; Shi et al., 1997). Viral RNA binding to VP39
is mediated by a hydrophobic pocket, which together with base
stacking, is believed to accommodate substrates in a sequence-
independent manner (Hodel et al., 1998, 1996).
Cap-snatching by viruses
Orthomyxoviruses, bunyaviruses, and arenaviruses generate cap
1 structures by removing them from host mRNA transcripts via a
mechanism called ‘cap-snatching’. During inﬂuenza virus infection,
cap 1 structures are acquired from host nuclear mRNAs and used to
prime viral RNA transcription. Both N-7 and 20-Omethylation of the
cap are required for efﬁcient transcriptional priming of inﬂuenza
(Bouloy et al., 1980), which is mediated via PB2, the cap-binding
protein of the inﬂuenza polymerase complex (PB1-PB2-PA) (Honda
et al., 1999). Following cap 1 binding the viral polymerase complex
cleaves the donor transcript 10 to 14 nucleotides downstream of the
cap 1 structure (Dias et al., 2009; Li et al., 2001; Plotch et al., 1979,
1981; Shi et al., 1995; Yuan et al., 2009). The polymerase complex
preferentially cleaves at purine residues and requires additional
sequence speciﬁcity, such as A/U at nucleotide positions 9–11, and
yields a 30-OH moiety (Kawakami et al., 1983; Plotch et al., 1981).
Bunyavirus cap-snatching exploits the host eukaryotic nonsense-
mediate mRNA decay pathway to generate cap 1 primers for viral
transcription (Cheng and Mir, 2012). Bunyavirus nucleocapsid
(N) binds preferentially to host cap 1 mRNA with premature stop
codons and then sequesters mRNA in processing (P) bodies within
the cytoplasm where RNA degradation takes place (Mir et al., 2008).
Association with N protects cap 1 from degradation by the host
decapping machinery, and results in the generation of cap 1 RNA
oligomers of 180 nucleotides (Hopkins et al., 2013; Mir et al., 2008).
The viral RNA-dependent RNA polymerase (L protein) then cleaves
cap 1 oligomers at a G residue approximately 14 nucleotides down-
stream of cap 1 to yield ‘mature’ cap 1 oligomers that serve as
primers for viral RNA transcription (Cheng and Mir, 2012; Jin and
Elliott, 1993; Mir et al., 2008, 2010; Patterson et al., 1984).
Less is known about the cap-snatching mechanism used by
arenaviruses (Lehmann et al., 2014; Morin et al., 2010; Raju et al.,
1990; Reguera et al., 2010). Analogous to bunyaviruses, the arena-
virus L protein has RNA-dependent RNA polymerase activity
(Lukashevich et al., 1997; Vieth et al., 2004). L protein also encodes
endonuclease and RNA-binding activity (Morin et al., 2010; Reguera
et al., 2010) and is predicted to facilitate cap-binding and cleavage
during cap-snatching through an undeﬁned mechanism.
Cap-independent translation
Unlike eukaryotic mRNA and some viral RNA, which have cap
1 structures and use cap-dependent translation mechanisms, other
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viruses have a 50 covalently-linked viral protein, VPg (picornaviruses
and caliciviruses) and/or an internal ribosomal entry site (IRES;
picornaviruses and hepaciviruses) within the 50-untranslated region
(UTR) to facilitate cap-independent translation. In contrast to cano-
nical cap-mediated translation where 43S pre-initiation complex
association with the mRNA cap structure is followed by ribosomal
scanning and 48S and 60S association, in IRES-mediated translation,
the 43S complex binds directly upstream of the IRES and does not
require ribosomal scanning or certain translation initiation factors
(eIF1, eIF1A, and eIF4E) (reviewed in Jackson et al. (2010) and Pestova
et al. (2001)). Viruses lacking 20-O methylation on their viral mRNA
(e.g., picornaviruses, caliciviruses, and hepaciviruses) may use cap-
independent translation mechanisms to overcome Iﬁt1 restriction. In
theory, this might occur in one of two ways: (a) the VPg and/or IRES
structures sterically hinder Iﬁt1 binding or (b) the IRES bypasses the
step at which IFIT1 inhibits eIF3-dependent translation.
RNA structure-mediated antagonism
Alphaviruses are RNA viruses that replicate in the cytoplasm,
translate via a cap-dependent mechanism, and yet lack a virally
encoded 20-O-methyltransferase or cap-snatching mechanism, and
thus should be restricted by IFIT1. Alphaviruses have a deﬁned cap
0 structure on the 50 end of their viral genomic and subgenomic RNA
(Hefti et al., 1975; Pettersson et al., 1980). Although previous studies
had shown that mutations in the Venezuelan equine encephalitis
virus (VEEV) 50-UTR (G-A at position 3) were attenuating (Kinney
et al., 1993, 1989) and resulted in enhanced sensitivity to type I IFN
treatment (White et al., 2001), the basis for this was unknown.
Analogously, mutations that altered the pathogenicity and IFN-
sensitivity of other alphaviruses (e.g., Sindbis and Semliki Forest
viruses) also mapped to the 50-UTR (Klimstra et al., 1999; Kobiler
et al., 1999; Kuhn et al., 1992; Logue et al., 2008). A recent study
explains these earlier ﬁndings as it showed that RNA secondary
structure in alphavirus 50-UTR antagonizes Iﬁt1 binding and antiviral
activity (Hyde et al., 2014). Mutations within the 50-UTR that affect
stable RNA structural elements enabled restriction by or antagonism
of Iﬁt1 in vitro and in vivo by altering binding of Iﬁt1 to viral RNA.
Although this mechanism has not yet been described for other
viruses, stable RNA structures are commonly found within the
50-UTR of many viruses, which might impact Iﬁt1 recognition in
other viral systems.
Conclusions
In higher eukaryotes, detection of viral RNA is critical for
initiating and establishing an antiviral state in cells. Cap 0 structures
on viral RNA can act as PAMPs that are sensed and restricted by the
IFN-induced gene, IFIT1. In contrast to other RNA sensors (TLRs and
RLRs) that induce signaling cascades that lead to the expression of
type I IFN and ISGs, Iﬁt1 appears to function predominantly as an
antiviral effector molecule. The evolution of multiple mechanisms
of antagonism by different families of RNA and DNA viruses
indicates the importance of Iﬁt1 as a key RNA sensor and antiviral
molecule. Pathogenic viruses have evolved ways to produce mRNA
with 50-ends that mimic host cellular mRNAs, including viral RNA
with N-7 and 20-Omethylation through several independent strate-
gies (encoding capping machinery, ‘cap-snatching’, or using host
capping machinery) or bypassing cap-dependent translation to use
other modalities (IRES-dependent) for protein synthesis. The ﬁnd-
ing that different IFIT proteins exhibit varying afﬁnities for distinct
RNA ligands suggests that IFIT genes may recognize additional viral
PAMPs, which have yet to be identiﬁed. The identiﬁcation of Iﬁt1 as
a key RNA sensor and antiviral effector and the importance of cap
1 structures in abrogating Iﬁt1-mediated restriction has provided a
rationale for the development of novel antiviral interventions,
including live attenuated vaccines (with 20-O-methylation or RNA
structure mutants) and small molecule inhibitors of viral 20-O
MTases.
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